https://doi.org/10.4081/jbr.2026.14728
Dysregulation of miR-205, BCL2, and YAP1 as molecular signatures of colorectal cancer in Iraqi patients: a case–control study
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 7 August 2026
Colorectal Cancer (CRC) is one of the most common malignancies globally, and its increasing prevalence in Iraq is an emerging health problem. This work analyzed the expression profiles of miR-205 (microRNA-205), BCL2 (B-cell lymphoma 2), and YAP1 gene in Iraqi CRC patients to evaluate the potential contribution towards diagnosis and prognosis. Eighty individual CRC and 40 healthy Control patients were recruited. Complete Blood Count (CBC) analysis was performed to assess White Blood Cell (WBC) concentrations, and Interleukin-18 (IL-18) and Interleukin-22 (IL-22) concentrations were determined by Enzyme-Linked Immunosorbent Assay (ELISA). Quantitative real-time Polymerase Chain Reaction (qRT-PCR) was utilized to quantify expression levels of miR-205, BCL2, and YAP1. Diagnostic efficacy was established by performing Receiver Operating Characteristic (ROC) curve analysis, and biomarker associations were evaluated using Pearson correlation. Differences in WBC count levels, IL-18, and IL-22 levels were non-significant in patients vs. controls. In contrast, miR-205 expression was significantly decreased in CRC patients (0.33-fold), whereas BCL2 and YAP1 were significantly up-regulated (1.92-fold and 1.44-fold, respectively). ROC analysis revealed that BCL2 showed the greatest diagnostic activity, with an area under the curve (AUC) of 0.880, and was followed by YAP1 (AUC: 0.736) and miR-205 (AUC: 0.700). There were significant correlations between miR-205/BCL2 and BCL2/YAP1, indicating coordinated roles in apoptosis blocking and tumor growth mechanisms. Collectively these results recommend the tumor suppressive role of miR-205 and the oncogenic role of BCL2 and YAP1 which could explain CRC phenotypes and therapy resistance. Overall, the study d=also suggest the potential of these genes as cancer detection candidate in the Iraqi population even within its limitations.
Downloads
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. DOI: https://doi.org/10.3322/caac.21492
2. Alrawi N. A review of breast cancer in Iraq and future therapy insights. Baghdad J Biochem Appl Biol Sci 2022;3:4–16. DOI: https://doi.org/10.47419/bjbabs.v3i01.64
3. Hassain AS, Al-Khafaji HMAH, Mohammed MQ. The role of miRNA-4516 in regulating Bruton’s tyrosine kinase expression and colorectal cancer progression in a sample of Iraqi population. J Biol Res Boll Soc Ital Biol Sper 2025;98:12987. DOI: https://doi.org/10.4081/jbr.2025.12987
4. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring, and therapeutics. A comprehensive review. EMBO Mol Med 2012;4:143–59. DOI: https://doi.org/10.1002/emmm.201100209
5. Iraqi Cancer Board, Ministry of Health, Republic of Iraq. Annual statistical report 2020. Baghdad: Republic of Iraq, 2021.
6. Iraqi Cancer Board, Ministry of Health, Republic of Iraq. Cancer registry of Iraq 2022: annual report. Baghdad: Republic of Iraq, 2024.
7. Korsmeyer SJ. Bcl-2 gene family and the regulation of programmed cell death. Cancer Res 1999;59:1693s-700s.
8. Chan S, Wang X, Wang Z, et al. Ctsg suppresses colorectal cancer progression through negative regulation of Akt/mTOR/Bcl2 signaling pathway. Int J Biol Sci 2023;19:2220. DOI: https://doi.org/10.7150/ijbs.82000
9. Song Y, Chen X, Huang R, Liu J. Dysregulated YAP1/Hippo pathway contributes to doxorubicin (ADM) resistance in acute myeloid leukemia (AML). Curr Pharm Biotechnol 2023;24:676–85. DOI: https://doi.org/10.2174/1389201023666220617150346
10. Noguchi S, Saito A, Nagase T. YAP/TAZ signaling as a molecular link between fibrosis and cancer. Int J Mol Sci 2018;19:3674. DOI: https://doi.org/10.3390/ijms19113674
11. Nouri K, Azad T, Ling M, et al. Identification of celastrol as a novel YAP-TEAD inhibitor for cancer therapy by high throughput screening with ultrasensitive YAP/TAZ–TEAD biosensors. Cancers 2019;11:1596. DOI: https://doi.org/10.3390/cancers11101596
12. Qasim Mohammed M, Hussein Alwan A, Amer Almukhtar A, Kareem Aneed Al-Saedi M. Revealing of TLR-9 gene polymorphisms by qPCR HRM technique and their influence on TLR-9 serum level in acute myeloid leukemia patients: case-control study. Cytokine 2024;182:156730. DOI: https://doi.org/10.1016/j.cyto.2024.156730
13. Mohammed MQ, Alwan AH, Almukhtar AA. Estimation of serum TLR-9, TNF-α, and IL-6 levels in the Iraqi patients diagnosed as acute myelogenous leukemia. Baghdad Sci J 2024;21:2182–90. DOI: https://doi.org/10.21123/bsj.2023.9056
14. Alshattawi S, Taleb RM, Shanyoor GJ, Aneed Al-Saedi MK, et al. Linking inflammation to gene expression: insights from GPR65, NUAK2, and OPG in ankylosing spondylitis. Gene Reports 2025;41:102315. DOI: https://doi.org/10.1016/j.genrep.2025.102315
15. Ghareeb ZA, Al-Khafaji HMA-H, Al-Saedi MKA. Low-density lipoprotein receptor-related protein-1 and mir-205 expression for cardiovascular disease in familial hypercholesterolemia and non-familial hypercholesterolemia in Iraqi population. Iran J Ichthyol 2021;8:246–54. DOI: https://doi.org/10.53293/jasn.2021.3691.1036
16. Hasan MJ, Bakheet MM, Ali HH, Aneed A-SMK, et al. Dual role of miR-150 in colorectal cancer progression: a quantitative real-time PCR study. Al-Rafidain J Med Sci 2025;8:221–9. DOI: https://doi.org/10.54133/ajms.v8i1.1757
17. Muhammed HJ, Al-Attar MM, Shubrem ZF, Al-Saedi MKA, et al. Quantitative real-time PCR analysis of circulating MicroRNA levels in blood samples from pediatric patients with epilepsy. Gene Reports 2025;39:102214. DOI: https://doi.org/10.1016/j.genrep.2025.102214
18. Al-Kafagi HMAA, Hussein NN A, Mohammed MQ, Hussein ZA, et al. The correlation between gene expression of growth differentiation factor 9B (GDF9B) gene and miR-378-5p in infertile women. Iraqi J Sci 2025;1560–9. DOI: https://doi.org/10.24996/ijs.2025.66.4.15
19. Samawi FT, Al-Dujaily SS, AL-Saidi MK, Abdulfattah SY, et al. Expression of protamine-1 gene and association with interleukin-12 gene in infertile men: a case-control study in Iraqi patients. Iraqi J Sci 2023;2798–808. DOI: https://doi.org/10.24996/ijs.2023.64.6.13
20. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101–8. DOI: https://doi.org/10.1038/nprot.2008.73
21. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Bioinforma Methods Protoc 1999;365–86. DOI: https://doi.org/10.1385/1-59259-192-2:365
22. Whitwell HJ, DiMaggio Jr P. HiLight-PTM: an online application to aid matching peptide pairs with isotopically labelled PTMs. Bioinformatics 2020;36:938–9. DOI: https://doi.org/10.1093/bioinformatics/btz654
23. Cavero Rozas GM, Mandujano JMC, Chombo YAF, et al. pyBrick-DNA: a python-based environment for automated genetic component assembly. J Comput Biol 2023;30:1315–21. DOI: https://doi.org/10.1089/cmb.2023.0008
24. Sun D, Ren X, Ari E, Korcsmaros T, et al. Discovering cooperative biomarkers for heterogeneous complex disease diagnoses. Brief Bioinform 2019;20:89–101. DOI: https://doi.org/10.1093/bib/bbx090
25. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78. DOI: https://doi.org/10.1016/S0140-6736(08)60269-X
26. Shankaran V, Ikeda H, Bruce AT, et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107–11. DOI: https://doi.org/10.1038/35074122
27. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–99. DOI: https://doi.org/10.1016/j.cell.2010.01.025
28. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436–44. DOI: https://doi.org/10.1038/nature07205
29. Caracausi M, Piovesan A, Antonaros F, et al. Systematic identification of human housekeeping genes possibly useful as references in gene expression studies. Mol Med Rep 2017;16:2397–410. DOI: https://doi.org/10.3892/mmr.2017.6944
30. Chauhan N, Dhasmana A, Jaggi M, et al. miR-205: a potential biomedicine for cancer therapy. Cells 2020;9:1957. DOI: https://doi.org/10.3390/cells9091957
31. Barber RD, Harmer DW, Coleman RA, Clark BJ. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 2005;21:389–95. DOI: https://doi.org/10.1152/physiolgenomics.00025.2005
32. Terana G, Abd-Alhaseeb M, Omran G, Okda TM. Quercetin potentiates 5-fluorouracil effects in human colon cancer cells through targeting the Wnt/β-catenin signalling pathway: the role of miR-27a. Contemp Oncol Onkol 2022;26:229–38. DOI: https://doi.org/10.5114/wo.2022.120361
33. Li WF, Atalla E, Dong J, Konopleva M. BCL2i-based therapies and emerging resistance in chronic lymphocytic leukemia. Cells 2024;13:1922. DOI: https://doi.org/10.3390/cells13221922
34. Ackers I, Malgor R. Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases. Diabetes Vasc Dis Res 2018;15:3–13. DOI: https://doi.org/10.1177/1479164117738442
35. Mouillet-Richard S, Laurent-Puig P. YAP/TAZ signalling in colorectal cancer: lessons from consensus molecular subtypes. Cancers 2020;12:3160. DOI: https://doi.org/10.3390/cancers12113160
36. Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med 2013;4:627–35.
37. Yang S, Berdine G. The receiver operating characteristic (ROC) curve. Southwest Respir Crit Care Chronicles 2017;5:34–36. DOI: https://doi.org/10.12746/swrccc.v5i19.391
38. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002;2:647–56. DOI: https://doi.org/10.1038/nrc883
39. Moroishi T, Hansen CG, Guan K-L. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 2015;15:73–9. DOI: https://doi.org/10.1038/nrc3876
40. Sur D, Advani S, Braithwaite D. MicroRNA panels as diagnostic biomarkers for colorectal cancer: a systematic review and meta-analysis. Front Med 2022;9:915226. DOI: https://doi.org/10.3389/fmed.2022.915226
41. Qian X, Zhang W, Yang H, Zhang L, et al. Role of yes-associated protein-1 in gastrointestinal cancers and hepatocellular carcinoma. Explor Res Hypothesis Med 2021;6:110. DOI: https://doi.org/10.14218/ERHM.2021.00017
42. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7–33. DOI: https://doi.org/10.3322/caac.21708
43. Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010;9:447–64. DOI: https://doi.org/10.1038/nrd3137
44. Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol 2021;18:663–72. DOI: https://doi.org/10.1038/s41571-021-00514-z
45. Moroishi T, Hayashi T, Pan W-W, et al. The Hippo pathway kinases LATS1/2 suppress cancer immunity. Cell 2016;167:1525–39. DOI: https://doi.org/10.1016/j.cell.2016.11.005
Ethics Approval
CRediT authorship contribution
Asmaa Mahmood Salman Al-Obaidi contributed to the methodology, investigation, and preparation of the original draft. Alaa H. Younus was responsible for data collection, project administration, and research supervision. Ghanyia Jasim Shanyoor contributed to the data curation, methodology, and manuscript writing. Sarab Hussain Khaleel contributed to visualization and critically reviewed and edited the manuscript. Mohanad K. Aneed Al Saedi conceived the study, performed the formal analysis and data interpretation, supervised the research, and critically reviewed and edited the manuscript. All authors have read and approved the final version of the manuscript.
Data Availability Statement
All data generated or analyzed during this study are included in this published article.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.